Mereo BioPharma (MREO) Debt Ratio (2017 - 2022)

Mereo BioPharma (MREO) has 6 years of Debt Ratio data on file, last reported at 0.13 in Q4 2022.

• Debt Ratio for Q4 2022 came in at 0.13, up 10.61% year-over-year; the trailing twelve-month figure through Dec 2022 was 0.03 (changed N/A YoY), and the FY2022 annual result was 0.17, up 47.61% from the prior year.
• Debt Ratio advanced to 0.13 in Q4 2022 per MREO's latest filing, from 0.11 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.32 in Q4 2018 and troughed at 0.11 in Q4 2021.
• A 5-year average of 0.21 and a median of 0.24 in 2019 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2018 and 2021: Debt Ratio surged 48.25% in 2018, then slumped 55.63% in 2021.
• A 5-year view of Debt Ratio shows it stood at 0.32 in 2018, then fell by 25.7% to 0.24 in 2019, then increased by 8.08% to 0.26 in 2020, then tumbled by 55.63% to 0.11 in 2021, then advanced by 10.61% to 0.13 in 2022.
• Business Quant data shows MREO's Debt Ratio at 0.13 in Q4 2022, 0.11 in Q4 2021, and 0.26 in Q4 2020.